Navigation Links
Misonix Announces Participation in 2nd International Workshop on Focal Therapy
Date:6/25/2009

FARMINGDALE, N.Y., June 25 /PRNewswire-FirstCall/ --Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, participated in the 2nd International Workshop on Focal Therapy and Imaging in Prostate and Kidney Cancer, which was held in Noordwijk, The Netherlands, June 10-13, 2009. The meeting was created to address the growing global demand for minimally invasive techniques to ablate urological tumors while maximizing organ preservation. High Intensity Focused Ultrasound and other advanced ablation modalities were featured throughout the program. In addition to the clinical presentations, Misonix exhibited and demonstrated the Sonablate(R) 500 High Intensity Focused Ultrasound ("HIFU") System to the approximately 350 clinicians in attendance.

The Sonablate is a state of the art HIFU instrument used in Europe, Latin America and Asia for trans-rectal ablation of tumors of the prostate gland. Characteristics of HIFU, when used for this purpose, are clinical outcomes similar to other treatment modalities, but with low instances of urinary incontinence and sexual impotence.

The company's SonaTherm HIFU System continues to be utilized in clinical evaluations at the University Hospital, Vienna, Austria, for the ablation of certain lesions of the kidney.

For several years, Sonablate's Visually Directed(TM) HIFU has been successfully used in Europe, in an outpatient setting, for whole gland ablation of prostate carcinoma, with minimal incidences of urinary incontinence and reduced reports of erectile dysfunction. Additional studies for the ablation of unifocal and unilateral prostate disease, while maximizing the preservation of surrounding tissue, are underway at University Col
'/>"/>

SOURCE Misonix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Misonix Subsidiary, Sonora Medical Systems, Achieves ISO 17025 Accreditation
2. Misonix Announces the Purchase of Patents From ProRhythm, Inc.
3. Misonix Announces Attendance at 22nd Annual Symposium on Advanced Wound Care
4. Misonix Announces Participation in Annual Diabetic Foot Global Conference
5. Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009
6. Misonix Announces New HIFU Distribution Agreement For Portugal
7. Misonix Announces New HIFU Distribution Agreement for Romania and Bulgaria
8. Misonix Announces New Distribution Agreement for Portugal
9. Misonix Announces the Sale of Its Ultrasonic Laboratory Business for $3.5 Million to iSonix LLC
10. Misonix Announces New Distribution Agreement for Belgium and Luxembourg
11. Misonix Announces New Sales Agency Agreement for Eastern Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... At the annual National League ... San Antonio, esteemed experts and thought leaders will ... in the way of successful organizational performance: resistance, ... faculty development opportunity is made possible through the ... to assist nurse educators to advance to leadership ...
(Date:12/21/2014)... In this report, the global powered ... product, and application. The market, by power source, ... By product, the market covers the handpieces; power ... market is further subdivided into drills, saws, reamers, ... shavers, wire/pin drivers, and others. Moreover, the power ...
(Date:12/21/2014)... Weddingshe.com, an outstanding online supplier of wedding dresses ... new selection of Cocktail Dresses for the winter 2014. ... newest fashion trends. , “We take pride ... . All of them are offered at greatly discounted ... every effort to offer a nice shopping experience for ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 Khanna Vision ... a guest at the Aspen Helicopters holiday event for ... a Santa with sleigh, flown by an aspen helicopter ... invisible; only Santa with sleigh was visible.(please see accompanying ... and night. Dr.Khanna has helped many pilots with Pi ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 AngelWeddingDress.com’s new ... There is a total of 1,000 new designs in ... the coming spring 2015. , AngelWeddingDress.com promises ... female shoppers with wardrobe essentials while many fashion trends ... problems, the customer service team at AngelWeddingDress.com is ready ...
Breaking Medicine News(10 mins):Health News:2015 NLN Leadership Conference February 5-7 San Antonio 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 4Health News:Stunning Cocktail Party Dresses from Weddingshe.com 2Health News:2015 Spring Wedding Dresses From AngelWeddingDress Just Released 2
... results across MDS, TORONTO, Sept. 6 /PRNewswire-FirstCall/ ... providing products and services to the global life ... For the quarter,MDS reported revenues of $321 million, ... from continuing operations of $0.07. Adjusted EBITDA,rose to ...
... product a proven treatment -, BELLEVILLE, ON, ... BNC), a research-based, technology-driven Canadian,biopharmaceutical company, today announced ... Australia in order to be able to respond ... continent,s equine influenza outbreak.,The outbreak began in August, ...
... N.Y., Sept. 6 /PRNewswire/, Who: Breast Cancer patients, survivors and ... (a breast cancer support center) on Thursday, September 6, What: ... ... wheels to encourage them to Keep ... to give cancer patients, survivors and caregivers a much needed ...
... Fairbank Farms, a national,ground beef producer, is ... Beef Patties. The ground beef patties, sold fresh,under ... consumers in New,England on Wednesday September 5, 2007 ... of caution, the product has been removed from ...
... Va., Sept. 5 AMERIGROUP,Corporation (NYSE: AGP ) ... Corporation have approved the sale of its assets,including TLC ... subject to regulatory approval by the State of Tennessee. ... of 2007. TLC Family Care Health Plan serves ...
... YORK, Sept. 5 Belfast Merger Co., a,wholly owned ... the expiration date for its cash tender offer for ... Inc. (Nasdaq: DADE ). The,tender offer has been ... September 26, 2007. The tender offer is being made ...
Cached Medicine News:Health News:MDS Reports Third Quarter 2007 Results 2Health News:MDS Reports Third Quarter 2007 Results 3Health News:MDS Reports Third Quarter 2007 Results 4Health News:MDS Reports Third Quarter 2007 Results 5Health News:MDS Reports Third Quarter 2007 Results 6Health News:MDS Reports Third Quarter 2007 Results 7Health News:MDS Reports Third Quarter 2007 Results 8Health News:MDS Reports Third Quarter 2007 Results 9Health News:MDS Reports Third Quarter 2007 Results 10Health News:MDS Reports Third Quarter 2007 Results 11Health News:MDS Reports Third Quarter 2007 Results 12Health News:MDS Reports Third Quarter 2007 Results 13Health News:MDS Reports Third Quarter 2007 Results 14Health News:MDS Reports Third Quarter 2007 Results 15Health News:MDS Reports Third Quarter 2007 Results 16Health News:MDS Reports Third Quarter 2007 Results 17Health News:MDS Reports Third Quarter 2007 Results 18Health News:MDS Reports Third Quarter 2007 Results 19Health News:MDS Reports Third Quarter 2007 Results 20Health News:MDS Reports Third Quarter 2007 Results 21Health News:MDS Reports Third Quarter 2007 Results 22Health News:MDS Reports Third Quarter 2007 Results 23Health News:MDS Reports Third Quarter 2007 Results 24Health News:MDS Reports Third Quarter 2007 Results 25Health News:MDS Reports Third Quarter 2007 Results 26Health News:MDS Reports Third Quarter 2007 Results 27Health News:MDS Reports Third Quarter 2007 Results 28Health News:MDS Reports Third Quarter 2007 Results 29Health News:MDS Reports Third Quarter 2007 Results 30Health News:MDS Reports Third Quarter 2007 Results 31Health News:MDS Reports Third Quarter 2007 Results 32Health News:MDS Reports Third Quarter 2007 Results 33Health News:Bioniche Responds to Australian Equine Influenza Outbreak 2Health News:Bioniche Responds to Australian Equine Influenza Outbreak 3Health News:New York City Cancer Patients, Survivors and Care Givers Encouraged to Keep Going(R) 2
(Date:12/17/2014)... Revenue and earnings above the previous year - ... In the past 2013/14 fiscal year (ended 30 September ... 4.287 billion (last year: EUR 4.190 billion) despite unfavorable currency ... million. "Overall, 2013/14 was a successful fiscal year for the ... CEO of Carl Zeiss AG. "Thanks to our broad portfolio ...
(Date:12/17/2014)... Ariz. , Dec. 17, 2014  Beamz ... state-of-the-art interactive music products, today announced that it ... a leading manufacturer and supplier of innovative prosthetic, ... As part of the agreement, RSL Steeper ... bundled solution specifically configured for use within UK ...
(Date:12/17/2014)... Dec. 17, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering, developing and commercializing innovative therapies addressing ... completion of enrollment in its first Phase 2a ... observations confirmed the 1-month findings that were reported ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
... A new highly sensitive and specific ... ELISA based on the detection of autoantibodies ... modified arginine residues in human serum or ... RA, the Anti-CCP assay provides an additional ...
... Rapid Plasma Reagin ... rapid detection and quantitative ... serum or plasma. Uses ... to detect reagin. Kits ...
Hemagglutination slide test for the qualitative detection and quantitative determination of antibodies to streptococcal extracellular antigens in serum, plasma, or whole blood....
Test for the quantitative determination of antideoxyribonuclease-B (ADNase-B) in serum....
Medicine Products: